Biological-Effect Modeling of Radioimmunotherapy for Non-Hodgkins Lymphoma: Determination of Model Parameters
dc.contributor.author | Roberson, Peter L. | |
dc.contributor.author | Wilderman, Scott J. | |
dc.contributor.author | Avram, Anca M. | |
dc.contributor.author | Kaminski, Mark S. | |
dc.contributor.author | Schipper, Matthew J. | |
dc.contributor.author | Dewaraja, Yuni K. | |
dc.date.accessioned | 2017-12-19T21:17:29Z | |
dc.date.available | 2017-12-19T21:17:29Z | |
dc.date.issued | 2013-10-08 | |
dc.identifier.citation | Roberson, Peter L.; Wilderman, Scott J.; Avram, Anca M.; Kaminski, Mark S.; Schipper, Matthew J.; Dewaraja, Yuni K. (2013). "Biological-Effect Modeling of Radioimmunotherapy for Non-Hodgkins Lymphoma: Determination of Model Parameters." Cancer Biotherapy and Radiopharmaceuticals 29 (1): 26-33. | |
dc.identifier.issn | 1084-9785 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/140326 | |
dc.description.abstract | Treatment with Tositumomab and 131I tositumomab anti-CD20 radioimmunotherapy (Bexxar) yields a nonradioactive antibody antitumor response (the so-called cold effect) and a radiation response. Numerical parameter determination by least-squares (LS) fitting was implemented for more accurate parameter estimates in equivalent biological-effect calculations. Methods: One hundred thirty-two tumors in 37 patients were followed using five or six SPECT/CT studies per patient, three each (typical) post-tracer (0.2 GBq) and post-therapy (?3 GBq) injections. The SPECT/CT data were used to calculate position- and time-dependent dose rates and antibody concentrations for each tumor. CT-defined tumor volumes were used to track tumor volume changes. Combined biological-effect and cell-clearance models were fit to tumor volume changes. Optimized parameter values determined using LS fitting were compared to previous fitted values that were determined by matching calculated to measured tumor volume changes using visual assessment. Absorbed dose sensitivity (α) and cold-effect sensitivity (?p) parameters were the primary fitted parameters, yielding equivalent biological-effect (E) values. Results: Individual parameter uncertainties were approximately 10% and 30% for α and ?p, respectively. LS versus previously fit parameter values were highly correlated, although the averaged α value decreased and the averaged ?p value increased for the LS fits compared to the previous fits. Correlation of E with 2-month tumor shrinkage data was similar for the two fitting techniques. The LS fitting yielded improved fit quality and likely improved parameter estimation. | |
dc.publisher | Mary Ann Liebert, Inc., publishers | |
dc.title | Biological-Effect Modeling of Radioimmunotherapy for Non-Hodgkins Lymphoma: Determination of Model Parameters | |
dc.type | Article | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/140326/1/cbr.2012.1467.pdf | |
dc.identifier.doi | 10.1089/cbr.2012.1467 | |
dc.identifier.source | Cancer Biotherapy and Radiopharmaceuticals | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.